The Company and Qidi Guhan Carry out Exchange and Study to Explore New Opportunities in the Health Industry

On June 17, Shen Fanshun, the Party Branch Secretary and Chairman of the company, led a delegation comprising representatives from R&D, production, marketing, strategy, and Party affairs departments, along with the head of the traceability company, to visit Guhan Traditional Chinese Medicine Co., Ltd., a subsidiary of Qidi Pharmaceutical Group, for an exchange and learning session.

Accompanied by Wen Ge, General Manager of Qidi Guhan, the Chun Guang Jiu Hui team toured the pilot production workshop and industrial tourism base of Guhan Traditional Chinese Medicine. They gained a comprehensive understanding of Qidi Guhan's development history, corporate culture, and its achievements in product R&D, production, and sales.

During the symposium, both parties engaged in multidimensional discussions on technological innovation pathways, market breakthrough strategies, and industrial collaboration models in the field of food-as-medicine health products. They unanimously agreed that with the continuous rise in public health awareness, the health industry is experiencing unprecedented development opportunities. Traditional Chinese medicine (TCM) enterprises should fully leverage their strengths by enhancing technological innovation and product development to meet consumers' increasingly diverse health needs. Simultaneously, they should strengthen industry exchanges and cooperation to achieve resource sharing and complementary advantages, collectively boosting the overall competitiveness of the TCM industry.

Going forward, both parties will deepen communication and collaboration in the field of health products, explore new opportunities for cooperation, and work together to advance the development of the traditional Chinese medicine industry and improve public health standards.

Important Notice: The Chun Guang Jiu Hui Food-Drug Integration Product System has been fully established. We are actively recruiting qualified professionals and partners. For franchise opportunities or collaborations, please contact Hu Xiujuan at 13581763776.

The company went to Jiangxi Baishen Pharmaceutical for exchange and study to explore the new path of high-quality development of Chinese medicine formula granules

On June 21, under the coordination of Sun Yuewu, Secretary-General of the Chinese Herbal Formula Granules Industry Alliance, Shen Fanshun, Chairman of the company, led a core team comprising production, R&D, procurement, and marketing representatives to Jiangxi Baishen Pharmaceutical Co., Ltd. for an exchange and learning session. The two sides discussed key issues including R&D breakthroughs, process optimization, market expansion, and supply chain development, jointly mapping out a collaborative blueprint.

Accompanied by Ms.Zhang Chaoxia, Executive Vice President of Baishen Pharmaceutical, the Chun Guang Jiu Hui team toured the company's exhibition hall and intelligent Chinese herbal decoction center, gaining a comprehensive understanding of Baishen Pharmaceutical's development history and industrial layout.

At the symposium, Chairman Fu Cheng of Baishen Pharmaceutical extended a warm welcome to Chun Guang Jiu Hui's delegation. He outlined the company's strategic vision for the industry and detailed its plans to strengthen competitiveness in the traditional Chinese medicine formula granules sector by leveraging the full industrial chain. The chairman emphasized that capitalizing on the unique advantages of Hunan-Jiangxi region's authentic medicinal resources holds strategic significance for the industry's development.

Shen Fanshun expressed gratitude for Baishen Pharmaceutical's warm hospitality and fully endorsed Chairman Fu Cheng's visionary strategic planning and open collaboration ethos. He elaborated on the historical evolution and current development status of Chun Guang Jiu Hui, noting that the traditional Chinese medicine formula granules industry is at a pivotal stage of growth. He urged both parties to actively engage in exchanges and cooperation, overcome developmental bottlenecks, and jointly promote the industry's healthy development.

Secretary-General Sun Yuewu highly commended the value of this exchange, describing it as a vivid demonstration of collaborative development among leading enterprises in the industry. By examining the evolution of national healthcare reform policies over the years, tracing the origins of medicinal materials, analyzing the supply chain of raw herbs, exploring process innovations and standardization, and investigating market integration and product value chains, he highlighted both opportunities and challenges for the development of the Chinese herbal formula granules industry.

Subsequently, the teams from both sides divided into groups based on their respective fields to conduct in-depth discussions and share experiences.

The exchange has strengthened mutual understanding and deepened mutual trust in technology and resources, laying a solid foundation for future comprehensive and in-depth cooperation.

The Company and Jingpai Zhizhengtang Pharmaceutical Exchange and Study, Explore the New Model of Strong Cooperation between the Same Industry Enterprises

On June 25, Wang Haitao, General Manager of Jingpai Zhizhengtang Pharmaceutical Co., Ltd., led a delegation to the company for a business exchange and to explore potential collaboration opportunities.

During the discussion, both parties focused on common industry pain points and future trends, exchanged views on market positioning, marketing strategies, and brand competitiveness enhancement, and shared practical experiences in optimizing sales systems, reducing costs through supply chain collaboration, and standardizing production processes.

Wang Haitao highly commended Chun Guang Jiu Hui's achievements in standardizing and modernizing traditional Chinese medicine, particularly its breakthroughs in ultra-fine powder technology, industrialized R&D of formula granules, and nationwide market network development. He also shared insights into Jing Pai Chi Zheng Tang's evolution in the formula granule sector and its future strategic roadmap.

Shen Fanshun, the company's Party branch secretary and chairman, emphasized that peer exchanges drive industry progress. The company is eager to share its expertise in technological innovation and quality management. He commended Jingpai Chizhengtang for its achievements in brand operations and market expansion, and expressed hope for deeper collaboration through more interactions in the future.

The exchange highlighted the shared vision of the two companies in inheriting and innovating traditional Chinese medicine, deepened mutual understanding and trust, and laid a solid foundation for their future comprehensive and in-depth cooperation.